Subscribe to RSS
DOI: 10.1055/s-0031-1279779
© Georg Thieme Verlag KG Stuttgart · New York
Growth Hormone, Ghrelin and Peptide YY Secretion after Oral Glucose Administration in Healthy and Obese Women
Publication History
received 25.01.2011
accepted 12.05.2011
Publication Date:
10 June 2011 (online)

Abstract
The mechanism of the altered GH secretion in obesity is unclear. There is evidence that oral glucose (OG) administration initially decreases and subsequently stimulates GH secretion. Ghrelin is a peptide that displays strong growth hormone-releasing activity. Its physiological importance on GH regulation is unclear. Our aim was to study fasting GH concentrations and their response to OG administration in relation with ghrelin secretion in obese and healthy women, in order to elucidate the hypothetical participation of ghrelin on post-oral glucose GH secretion. 36 women were included in the study. After an overnight fast, 75 g of oral glucose was administered; glucose, insulin, ghrelin, and PYY1–36 were obtained at baseline and during 300 min. The area under the curve between 0 and 300 min (AUC) of GH μ/l·min) was lower in obese patients than in controls; 262.5±57.5 vs. 534.9±95.6, p=0.01, for obese and controls respectively. GH peak (μg/l) was lower in obese patients than in controls; 3.7±0.7 vs. 7.1±1.0, p=0.012, for obese and controls, respectively. The AUC of total ghrelin (pg/ml·min) was lower in obese patients than in controls; 233 032±12 641 vs. 333 697±29 877, p=0.004, for the obese patients and controls respectively. PYY1–36 was similar in obese and healthy women after OG. There were significant correlations between the different indices of post-oral glucose GH and ghrelin secretion. These data suggest that ghrelin is a physiological regulator of GH in the post-oral glucose state, and the decreased ghrelin secretion could be one of the mechanisms responsible for the altered GH secretion in obesity.
Key words
GH - oral glucose - women - obesity - ghrelin
References
- 1
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K.
Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
Nature.
1999;
402
656-660
MissingFormLabel
- 2
Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH.
A receptor in pituitary and hypothalamus that functions in growth hormone release.
Science.
1996;
273
974-977
MissingFormLabel
- 3
Cordido F, Penalva A, Dieguez C, Casanueva FF.
Massive growth hormone (GH) discharge in obese subjects after the combined administration
of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability
in obesity.
J Clin Endocrinol Metab.
1993;
76
819-823
MissingFormLabel
- 4
Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F.
Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH)
in obese patients.
Clin Endocrinol (Oxf).
2004;
61
250-255
MissingFormLabel
- 5
Alaioubi B, Mann K, Petersenn S.
Diagnosis of growth hormone deficiency in adults: provocative testing with GHRP6 in
comparison to the insulin tolerance test.
Horm Metab Res.
2009;
41
238-243
MissingFormLabel
- 6
Lanfranco F, Motta G, Baldi M, Gasco V, Grottoli S, Benso A, Broglio F, Ghigo E.
Ghrelin and anterior pituitary function.
Front Horm Res.
2010;
38
206-211
MissingFormLabel
- 7
Espelund U, Hansen TK, Højlund K, Beck-Nielsen H, Clausen JT, Hansen BS, Orskov H, Jørgensen JO, Frystyk J.
Fasting unmasks a strong inverse association between ghrelin and cortisol in serum:
studies in obese and normal-weight subjects.
J Clin Endocrinol Metab.
2005;
90
741-746
MissingFormLabel
- 8
Norrelund H.
The metabolic role of growth hormone in humans with particular reference to fasting.
Growth Horm IGF Res.
2005;
15
95-122
MissingFormLabel
- 9
Natalucci G, Riedl S, Gleiss A, Zidek T, Frisch H.
Spontaneous 24-h ghrelin secretion pattern in fasting subjects: maintenance of a meal-related
pattern.
Eur J Endocrinol.
2005;
152
845-850
MissingFormLabel
- 10
Avram AM, Jaffe CA, Symons KV, Barkan AL.
Endogenous circulating ghrelin does not mediate growth hormone rhythmicity or response
to fasting.
J Clin Endocrinol Metab.
2005;
90
2982-2987
MissingFormLabel
- 11
Dall R, Kanaley J, Hansen TK, Møller N, Christiansen JS, Hosoda H, Kangawa K, Jørgensen JO.
Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient
patients.
Eur J Endocrinol.
2002;
147
65-70
MissingFormLabel
- 12
Pérez-Fontán M, Cordido F, Rodríguez-Carmona A, García-Naveiro R, Isidro ML, Villaverde P, García-Buela J.
Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic
glucose-based dialysate in patients with chronic renal failure.
Kidney Int.
2005;
68
2877-2885
MissingFormLabel
- 13
Isidro ML, Nemina R, Garcia-Buela J, Sangiao-Alvarellos S, Cordido F.
Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients.
Neuro Endocrinol Lett.
2007;
28
596-603
MissingFormLabel
- 14
Muller AF, Lamberts SW, Janssen JA, Hofland LJ, Koetsveld PV, Bidlingmaier M, Strasburger CJ, Ghigo E, Van der Lely AJ.
Ghrelin drives GH secretion during fasting in man.
Eur J Endocrinol.
2002;
146
203-207
MissingFormLabel
- 15
Koutkia P, Schurgin S, Berry J, Breu J, Lee BS, Klibanski A, Grinspoon S.
Reciprocal changes in endogenous ghrelin and growth hormone during fasting in healthy
women.
Am J Physiol Endocrinol Metab.
2005;
289
E814-E822
MissingFormLabel
- 16
Misra M, Miller KK, Kuo K, Griffin K, Stewart V, Hunter E, Herzog DB, Klibanski A.
Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy
adolescents.
Am J Physiol Endocrinol Metab.
2005;
289
E347-E356
MissingFormLabel
- 17
Nass R, Farhy LS, Liu J, Prudom CE, Johnson ML, Veldhuis P, Pezzoli SS, Oliveri MC, Gaylinn BD, Geysen HM, Thorner MO.
Evidence for acyl-ghrelin modulation of growth hormone release in the fed state.
J Clin Endocrinol Metab.
2008;
93
1988-1994
MissingFormLabel
- 18
Lloyd B, Ravi P, Mendes N, Klibanski A, Misra M.
Peptide YY levels across pubertal stages and associations with growth hormone.
J Clin Endocrinol Metab.
2010;
95
2957-2962
MissingFormLabel
- 19
Cordido F, Casanueva FF, Dieguez C.
Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness
to GH-releasing hormone administration in obese subjects: evidence for hypothalamic
somatostatinergic participation in the blunted GH release of obesity.
J Clin Endocrinol Metab.
1989;
68
290-293
MissingFormLabel
- 20
Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J, Skakkebae NE.
Massive weight loss restores 24-h growth hormone release profiles and serum insulin-like
growth factor-I levels in obese subjects.
J Clin Endocrinol Metab.
1995;
80
1407-1415
MissingFormLabel
- 21
Kelijman M, Frohman LA.
Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary
manipulation in obese and nonobese subjects.
J Clin Endocrinol Metab.
1988;
66
489-494
MissingFormLabel
- 22
Furuhata Y, Kagaya R, Hirabayashi K, Ikeda A, Chang KT, Nishihara M, Takahashi M.
Development of obesity in transgenic rats with low circulating growth hormone levels:
involvement of leptin resistance.
Eur J Endocrinol.
2000;
143
535-541
MissingFormLabel
- 23
Mekala KC, Tritos NA.
Effects of Recombinant Human Growth Hormone Therapy in Obesity in Adults – a Meta-Analysis.
J Clin Endocrinol Metab.
2009;
94
130-137
MissingFormLabel
- 24
Valcavi R, Zini M, Volta C, Ghizzoni L, Azzarito C, Bernasconi S, Portioli I.
Effects of oral glucose administration on spontaneous and growth hormone (GH)-releasing
hormone-stimulated GH release in children and adults.
J Clin Endocrinol Metab.
1994;
79
1152-1157
MissingFormLabel
- 25
Grottoli S, Procopio M, Maccario M, Zini M, Oleandri SE, Tassone F, Valcavi R, Ghigo E.
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory,
effect on somatotrope secretion.
J Clin Endocrinol Metab.
1997;
82
2261-2265
MissingFormLabel
- 26
Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S.
Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin
secretion.
J Clin Endocrinol Metab.
2002;
87
240-244
MissingFormLabel
- 27
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS.
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in
humans.
Diabetes.
2001;
50
1714-1719
MissingFormLabel
- 28
Kojima M, Kangawa K.
Ghrelin: structure and function.
Physiol Rev.
2005;
85
495-522
MissingFormLabel
- 29
Benedini S, Codella R, Caumo A, Marangoni F, Luzi L.
Different circulating ghrelin responses to isoglucidic snack food in healthy individuals.
Horm Metab Res.
2011;
43
135-140
MissingFormLabel
- 30
Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ.
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.
N Engl J Med.
2002;
346
1623-1630
MissingFormLabel
- 31
Karra E, Batterham RL.
The role of gut hormones in the regulation of body weight and energy homeostasis.
Mol Cell Endocrinol.
2010;
316
120-128
MissingFormLabel
- 32
Cordido F, Garcia-Buela J, Sangiao-Alvarellos S, Martinez T, Vidal O.
The decreased growth hormone response to growth hormone releasing hormone in obesity
is associated to cardiometabolic risk factors.
Mediators Inflamm.
2010;
2010
434–562
MissingFormLabel
- 33
van der Lely AJ, Tschop M, Heiman ML, Ghigo E.
Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.
Endocr Rev.
2004;
25
426-457
MissingFormLabel
- 34
Osterstock G, Escobar P, Mitutsova V, Gouty-Colomer LA, Fontanaud P, Molino F, Fehrentz JA, Carmignac D, Martinez J, Guerineau NC, Robinson IC, Mollard P, Méry PF.
Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate
nucleus.
PLoS ONE.
2010;
5
e9159
MissingFormLabel
- 35
Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell Jr FE, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO.
Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy
older adults: a randomized trial.
Ann Intern Med.
2008;
149
601-611
MissingFormLabel
- 36
Zizzari P, Halem H, Taylor J, Dong JZ, Datta R, Culler MD, Epelbaum J, Bluet-Pajot MT.
Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying
GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor.
Endocrinology.
2005;
146
3836-3842
MissingFormLabel
- 37
Pantel J, Legendre M, Nivot S, Morisset S, Vie-Luton MP, le Bouc Y, Epelbaum J, Amselem S.
Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor.
J Clin Endocrinol Metab.
2009;
94
4334-4341
MissingFormLabel
- 38
Sun Y, Wang P, Zheng H, Smith RG.
Ghrelin stimulation of growth hormone release and appetite is mediated through the
growth hormone secretagogue receptor.
P Natl Acad Sci USA.
2004;
101
4679-4684
MissingFormLabel
- 39
Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, Valenzuela DM, Yancopoulos GD, Goldstein JL, Brown MS.
Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival
of calorie-restricted mice.
P Natl Acad Sci USA.
2010;
107
7467-7472
MissingFormLabel
- 40
Broglio F, Benso A, Gottero C, Prodam F, Grottoli S, Tassone F, Maccario M, Casanueva FF, Dieguez C, Deghenghi R, Ghigo E, Arvat E.
Effects of glucose, free fatty acids or arginine load on the GH-releasing activity
of ghrelin in humans.
Clin Endocrinol (Oxf).
2002;
57
265-271
MissingFormLabel
- 41
Cordido F, Fernandez T, Martinez T, Peñalva A, Peinó R, Casanueva FF, Dieguez C.
Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone
(GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
J Clin Endocrinol Metab.
1998;
83
4350-4354
MissingFormLabel
- 42
Vestergaard ET, Dall R, Lange KH, Kjaer M, Christiansen JS, Jorgensen JO.
The ghrelin response to exercise before and after growth hormone administration.
J Clin Endocrinol Metab.
2007;
92
297-303
MissingFormLabel
- 43
Gormsen LC, Nielsen C, Gjedsted J, Gjedde S, Vestergaard ET, Christiansen JS, Jørgensen JO, Møller N.
Effects of free fatty acids, growth hormone and growth hormone receptor blockade on
serum ghrelin levels in humans.
Clin Endocrinol (Oxf).
2007;
66
641-645
MissingFormLabel
- 44
Yamashita S, Melmed S.
Insulin regulation of rat growth hormone gene transcription.
J Clin Invest.
1986;
78
1008-1014
MissingFormLabel
- 45
Clasey JL, Weltman A, Patrie J, Weltman JY, Pezzoli S, Bouchard C, Thorner MO, Hartman ML.
Abdominal visceral fat and fasting insulin are important predictors of 24-h GH release
independent of age, gender, and other physiological factors.
J Clin Endocrinol Metab.
2001;
86
3845-3852
MissingFormLabel
- 46
Haqq AM, Farooqi IS, O’Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, LaFranchi SH, Purnell JQ.
Serum ghrelin levels are inversely correlated with body mass index, age, and insulin
concentrations in normal children and are markedly increased in Prader-Willi syndrome.
J Clin Endocrinol Metab.
2003;
88
174-178
MissingFormLabel
- 47
McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE.
Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative
to equally obese insulin-sensitive controls.
J Clin Endocrinol Metab.
2004;
89
1630-1635
MissingFormLabel
- 48
Hotta M, Ohwada R, Katakami H, Shibasaki T, Hizuka N, Takano K.
Plasma levels of intact and degraded ghrelin and their responses to glucose infusion
in anorexia nervosa.
J Clin Endocrinol Metab.
2004;
89
5707-5712
MissingFormLabel
- 49
Blatnik M, Soderstrom CI.
A practical guide for the stabilization of acylghrelin in human blood collections.
Clin Endocrinol (Oxf).
2011;
74
325-331
MissingFormLabel
- 50
Tassone F, Broglio F, Destefanis S, Rovere S, Benso A, Gottero C, Prodam F, Rossetto R, Gauna C, van der Lely AJ, Ghigo E, Maccario M.
Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity.
J Clin Endocrinol Metab.
2003;
88
5478-5483
MissingFormLabel
- 51
Johannsson G.
Central adiposity as an important confounder in the diagnosis of adult growth hormone
deficiency.
J Clin Endocrinol Metab.
2008;
93
4221-4223
MissingFormLabel
- 52
De Marinis L, Bianchi A, Mancini A, Gentilella R, Perrelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D, Tacchino RM.
Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic
diversion: relationships with insulin and body composition.
J Clin Endocrinol Metab.
2004;
89
174-180
MissingFormLabel
- 53
Makimura H, Stanley T, Mun D, You SM, Grinspoon S.
The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine
stimulation testing in men.
J Clin Endocrinol Metab.
2008;
93
4254-4260
MissingFormLabel
- 54
Rasmussen MH, Juul A, Hilsted J.
Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.
Obesity (Silver Spring).
2007;
15
879-886
MissingFormLabel
Correspondence
F. CordidoMD
Servicio de Endocrinología
University Hospital A Coruña
Xubias de Arriba 84
15006 La Coruña
Spain
Phone: +34/98/117 8000
Fax: +34/98/117 8204
Email: Fernando.Cordido.Carballido@sergas.es